SS-31 Peptide Vial 50mg

Description

This product is intended for research purposes only. To be used by trained research professionals only.

The SS-31 peptide vial is a high-purity lyophilised peptide designed for advanced research purposes. It is supplied in a sterile glass vial, ensuring maximum stability and contaminant-free storage. It is a synthetic peptide renowned for its ability to target mitochondria selectively, where it interacts with cardiolipin to aid in reducing oxidative stress and enhancing mitochondrial function.

Providing the compound in lyophilised form offers many benefits. Lyophilisation extends its shelf life while preserving its structure and activity until reconstitution. The sterile glass vial packaging ensures the peptide remains uncontaminated, making it ideal for researchers needing precision and reliability. With consistent quality and efficacy, this product is a valuable tool for mitochondrial research, particularly in studies on aging, neurodegeneration, and metabolic disorders.

SS-31, also known as elamipretide, is a peptide with unique mitochondrial-targeting abilities, offering significant benefits in research and clinical settings. It localizes to the inner mitochondrial membrane, stabilizing cardiolipin, a phospholipid essential for healthy mitochondrial structure and function. By reducing mitochondrial reactive oxygen species (ROS) and enhancing ATP synthesis, SS-31 improves energy production and supports the electron transport chain, addressing mitochondrial dysfunction—a key factor in many degenerative diseases.

This makes it particularly relevant for conditions like cardiovascular diseases, neurodegenerative disorders, and age-related muscle weakness. Additionally, Europe research has been shown to protects cells from oxidative damage and stress-induced apoptosis, safeguarding mitochondrial proteins and supporting overall energy production.

Clinical trials have shown its potential to improve exercise capacity, restore energy metabolism, and reduce oxidative cell death. With precise targeting of the mitochondrial membrane, minimal off-target effects, and strong evidence from advanced research, SS-31 shows promise in treating mitochondrial diseases and promoting healthy aging.